Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses https://t.co/ePq0OuYzXg

@AndreaWoll5 "wipes out those antibodies" 🤣 Für die ganz hinten nochmals langsam: es geht um Herstellung von mAbs (monoclonal antibodies), für die man Nucleocapsid Antikörper braucht. Diese werden NUR nach Infektion gebildet, nicht nach Impfung. Untermauer

RT @DrImranSheikh: Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react w…

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses https://t.co/gHfAQawM6w https://t.co/fptYL8mXS1